Diligence memo · auto-generated · as of July 2, 2026
CardioWise, Inc.
CardioWise, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
CardioWise, Inc. operates in Other Health Care, based in FAYETTEVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
CardioWise, Inc. has raised $4.8M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2025-09-08.
Most recent recorded round closed around 2025-09-08.
Valuation (modeled)modeled
Provath models CardioWise, Inc. at approximately $8.0M (range $2.5M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.89× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 28 months.
Last raise 10 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 10.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 63% of Other Health Care peers (5377 compared).
Modeled value ranks above 30% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.